Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MAXN
11551
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $92.6K | ﹤0.01% |
12,287
+9,426
| +329% | +$73K |
2020 Q3
17 quarters
|
|
11552
Chefs' Warehouse
CHEF
$4.53B
| $92.5K | ﹤0.01% |
+1,876
| New | +$81.7K |
2024 Q4
0 quarters
|
|
11553
CALL
C4 Therapeutics
CCCC
$347M
| $92.5K | ﹤0.01% |
25,700
-59,400
| -70% | -$295K |
2021 Q2
14 quarters
|
|
11554
CALL
Lindblad Expeditions
LIND
$2.29B
| $92.5K | ﹤0.01% |
7,800
-20,100
| -72% | -$230K |
2022 Q4
8 quarters
|
|
|
RAPT
11555
CALL
DELISTED
RAPT Therapeutics
RAPT
| $92.4K | ﹤0.01% |
7,313
+4,113
| +129% | +$52.2K |
2020 Q4
16 quarters
|
|
11556
PUT
Amplify Lithium & Battery Technology ETF
BATT
$111M
| $92.4K | ﹤0.01% |
+10,500
| New | +$98.4K |
2024 Q4
0 quarters
|
|
|
BCYC
11557
PUT
Bicycle Therapeutics
BCYC
$261M
| $92.4K | ﹤0.01% |
6,600
+500
| +8% | +$10.7K |
2022 Q4
8 quarters
|
|
11558
CALL
Lightwave Logic
LWLG
$837M
| $92.4K | ﹤0.01% |
44,000
-6,400
| -13% | -$18.3K |
2021 Q4
12 quarters
|
|
|
PHX
11559
DELISTED
PHX Minerals
PHX
| $92.4K | ﹤0.01% |
23,089
+19,989
| +645% | +$73.5K |
2024 Q2
2 quarters
|
|
11560
Zedge
ZDGE
$46.6M
| $92.3K | ﹤0.01% |
34,322
-24,786
| -42% | -$72.1K |
2020 Q3
17 quarters
|
|
|
PNF
11561
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $92.3K | ﹤0.01% |
+12,420
| New | +$98.9K |
2024 Q4
0 quarters
|
|
11562
CALL
Vivid Seats
SEAT
$37.7M
| $92.1K | ﹤0.01% |
995
+940
| +1,709% | +$70.1K |
2024 Q3
1 quarter
|
|
|
BHR
11563
CALL
Braemar Hotels & Resorts
BHR
$101M
| $92.1K | ﹤0.01% |
30,700
+7,700
| +33% | +$24.9K |
2020 Q1
19 quarters
|
|
11564
CALL
Dole
DOLE
$1.21B
| $92.1K | ﹤0.01% |
6,800
+3,900
| +134% | +$59.9K |
2021 Q3
13 quarters
|
|
11565
PUT
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36B
| $92.1K | ﹤0.01% |
1,800
-11,100
| -86% | -$591K |
2020 Q4
16 quarters
|
|
11566
CALL
MacroGenics
MGNX
$226M
| $92K | ﹤0.01% |
28,300
-38,100
| -57% | -$137K |
2022 Q4
8 quarters
|
|
11567
PUT
NetSol Technologies
NTWK
$74.8M
| $92K | ﹤0.01% |
35,100
+15,300
| +77% | +$43.9K |
2024 Q1
3 quarters
|
|
|
PFN
11568
PIMCO Income Strategy Fund II
PFN
$612M
| $91.9K | ﹤0.01% |
+12,332
| New | +$92.8K |
2024 Q4
0 quarters
|
|
11569
PUT
Hyliion Holdings
HYLN
$688M
| $91.9K | ﹤0.01% |
35,200
-27,900
| -44% | -$77.6K |
2020 Q3
17 quarters
|
|
11570
PUT
Sotera Health
SHC
$5.11B
| $91.7K | ﹤0.01% |
6,700
-3,600
| -35% | -$52.2K |
2022 Q3
9 quarters
|
|
11571
Exagen
XGN
$201M
| $91.6K | ﹤0.01% |
22,349
-660
| -3% | -$2.38K |
2023 Q4
4 quarters
|
|
11572
CALL
York Water
YORW
$500M
| $91.6K | ﹤0.01% |
2,800
-3,100
| -53% | -$110K |
2022 Q4
8 quarters
|
|
11573
AEye
LIDR
$49.5M
| $91.5K | ﹤0.01% |
+72,085
| New | +$83.2K |
2024 Q4
0 quarters
|
|
|
GLDD
11574
PUT
DELISTED
Great Lakes Dredge & Dock
GLDD
| $91.4K | ﹤0.01% |
8,100
+4,900
| +153% | +$58.6K |
2022 Q4
8 quarters
|
|
|
ZYXI
11575
DELISTED
Zynex
ZYXI
| $91.4K | ﹤0.01% |
11,415
-44,413
| -80% | -$366K |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.